BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14745718)

  • 1. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
    Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF
    Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
    Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
    Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
    Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
    Lau SK; Desrochers MJ; Luthringer DJ
    Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
    Goldstein NS; Thomas M
    Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival.
    Haque AK; Syed S; Lele SM; Freeman DH; Adegboyega PA
    Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):103-9. PubMed ID: 12051626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchioloalveolar differentiation in lung adenocarcinomas.
    Dukić N; Babić B; Eri Z; Zec D; Lovrenski A; Kolarov V
    Bosn J Basic Med Sci; 2011 Nov; 11(4):248-52. PubMed ID: 22117833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
    Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G
    Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
    Saad RS; Liu Y; Han H; Landreneau RJ; Silverman JF
    Mod Pathol; 2004 Oct; 17(10):1235-42. PubMed ID: 15167937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice.
    Casali C; Rossi G; Marchioni A; Sartori G; Maselli F; Longo L; Tallarico E; Morandi U
    J Thorac Oncol; 2010 Jun; 5(6):830-6. PubMed ID: 20521350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
    Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
    Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
    Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation.
    Sarantopoulos GP; Gui D; Shintaku P; Hong L; Wang YY; Yap CS; Fishbein MC
    Arch Pathol Lab Med; 2004 Apr; 128(4):406-14. PubMed ID: 15043468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma.
    McDonald JW; Pilgram TK
    Histopathology; 1999 May; 34(5):439-46. PubMed ID: 10231419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
    Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
    Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
    Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
    J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
    Hidaka N; Nagao T; Asoh A; Kondo Y; Nagao K
    Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. An immunohistochemical study.
    Ohori NP; Yousem SA; Griffin J; Stanis K; Stetler-Stevenson WG; Colby TV; Sonmez-Alpan E
    Am J Surg Pathol; 1992 Jul; 16(7):675-86. PubMed ID: 1326898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.